CRAVATEX LTD.

Cravatex Ltd has announced that its Board of Directors will convene on November 3, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for both standalone and consolidated operations for the quarter and half-year ended September 30, 2026. This announcement is made in compliance with SEBI regulations.

Cravatex Ltd has announced the closure of its trading window for designated persons and their dependents. This closure will be effective from October 1st, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30th, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent potential insider trading activities.

Cravatex Ltd announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results. The company's statutory auditors have provided a limited review report on these results. The filing includes details of the review process and confirms that no material misstatements were found. The results are prepared in accordance with Indian Accounting Standards (Ind AS).

Cravatex Ltd announced that its Board of Directors has approved the unaudited financial results for the quarter ended June 30, 2026. The results were approved during a board meeting held on August 12, 2026. Both standalone and consolidated financial results, along with the limited review report from the statutory auditors, have been submitted. The meeting commenced at 3:30 p.m. and concluded at 4:25 p.m.

Cravatex Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results for the quarter ending June 30, 2026. The results will be presented on both a standalone and consolidated basis. This disclosure is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Cravatex Ltd has issued a letter providing the weblink for its Annual Report 2025-26 to shareholders who have not registered their email addresses. This action is in compliance with SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The company also announced its 74th Annual General Meeting (AGM) scheduled for July 31, 2026, to be held via Video Conferencing. Shareholders holding physical securities are reminded to update their KYC details and consider dematerializing their shares as per SEBI mandates.

Cravatex Ltd has announced its 74th Annual General Meeting (AGM) will be held on Friday, July 31, 2026, at 3:30 p.m. IST. The meeting will be conducted virtually via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company has attached the Notice of AGM along with its Annual Report for the Financial Year 2025-26. Key agenda items include the adoption of audited financial statements for FY2025-26 and the declaration of a final dividend of ₹13 per equity share (130%). One director retiring by rotation will also be considered for re-appointment.

Cravatex Ltd has announced its 74th Annual General Meeting (AGM) will be held on Friday, July 31, 2026, at 3:30 p.m. IST. The meeting will be conducted through Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company will present the Audited Financial Statements for the fiscal year ended March 31, 2026, including the Balance Sheet, Profit & Loss, and Cash Flow Statements, along with the Board's and Auditors' reports. A final dividend of ₹13 per equity share (130%) for FY26 is proposed. The AGM notice and Annual Report for FY25-26 have been dispatched electronically to members and are available on the company's website and NSDL's e-voting portal.

Cravatex Ltd has announced the closure of its trading window for designated persons and their dependents, effective July 15, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's code of conduct. The trading window will reopen 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. This action is a standard procedure to prevent potential insider trading during sensitive financial reporting periods.

Cravatex Ltd has announced the record date for its 74th Annual General Meeting (AGM) and entitlement to the final dividend for the financial year ended March 31, 2026. The record date is set for Friday, July 24, 2026, subject to approval by the members at the AGM.